| Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways X Zheng, S Linke, JM Dias, X Zheng, K Gradin, TP Wallis, BR Hamilton, ... Proceedings of the National Academy of Sciences 105 (9), 3368-3373, 2008 | 306 | 2008 |
| The subtle side to hypoxia inducible factor (HIFá) regulation RL Bilton, GW Booker European Journal of Biochemistry 270 (5), 791-798, 2003 | 238 | 2003 |
| HIF-1: master and commander of the hypoxic world: a pharmacological approach to its regulation by siRNAs NM Mazure, MC Brahimi-Horn, MA Berta, E Benizri, RL Bilton, F Dayan, ... Biochemical pharmacology 68 (6), 971-980, 2004 | 237 | 2004 |
| Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1á and is not induced by hypoxia or HIF R Bilton, N Mazure, E Trottier, M Hattab, MA Déry, DE Richard, ... Journal of Biological Chemistry 280 (35), 31132-31140, 2005 | 138 | 2005 |
| The Batten disease gene product (CLN3p) is a Golgi integral membrane protein G Kremmidiotis, IL Lensink, RL Bilton, E Woollatt, TK Chataway, ... Human molecular genetics 8 (3), 523-531, 1999 | 91 | 1999 |
| Differences in hydroxylation and binding of Notch and HIF-1á demonstrate substrate selectivity for factor inhibiting HIF-1 (FIH-1) SE Wilkins, J Hyvärinen, J Chicher, JJ Gorman, DJ Peet, RL Bilton, ... The international journal of biochemistry & cell biology 41 (7), 1563-1571, 2009 | 70 | 2009 |
| Activation of HIF‐1á in exponentially growing cells via hypoxic stimulation is independent of the Akt/mTOR pathway F Dayan, RL Bilton, J Laferrière, E Trottier, D Roux, J Pouyssegur, ... Journal of cellular physiology 218 (1), 167-174, 2009 | 54 | 2009 |
| Direct health and residential care costs of people living with dementia in Australian residential aged care ES Gnanamanickam, SM Dyer, R Milte, SL Harrison, E Liu, T Easton, ... International journal of geriatric psychiatry 33 (7), 859-866, 2018 | 44 | 2018 |
| ARDent about acetylation and deacetylation in hypoxia signalling R Bilton, E Trottier, J Pouysségur, MC Brahimi-Horn Trends in cell biology 16 (12), 616-621, 2006 | 42 | 2006 |
| Genomic structure and expression analysis of the spastic paraplegia gene, SPG7 C Settasatian, SA Whitmore, J Crawford, RL Bilton, AM Cleton-Jansen, ... Human genetics 105, 139-144, 1999 | 38 | 1999 |
| Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised … EE Roughead, NL Pratt, G Parfitt, D Rowett, LM Kalisch-Ellett, ... Age and Ageing 51 (4), afac092, 2022 | 15 | 2022 |
| Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing … R Lim, L Bereznicki, M Corlis, LMK Ellett, AC Kang, T Merlin, G Parfitt, ... BMJ open 10 (4), e032851, 2020 | 14 | 2020 |
| Using wrist-worn accelerometers to identify the impact of medicines with anticholinergic or sedative properties on sedentary time: a 12-month prospective analysis R Lim, D Dumuid, G Parfitt, T Stanford, D Post, R Bilton, LMK Ellett, N Pratt, ... Maturitas 172, 9-14, 2023 | 4 | 2023 |
| Prevalence and preventability of adverse medicine events in a Sample of Australian aged-care residents: a secondary analysis of data from the ReMInDAR Trial LM Kalisch Ellett, G Dorj, AQ Andrade, RL Bilton, D Rowett, J Whitehouse, ... Drug Safety 46 (5), 493-500, 2023 | 3 | 2023 |
| Pharmacists as patient advocates: a series of case studies illustrating the impacts of a regular pharmacist service in residential aged care (nursing homes) R Lim, R Bilton, G Dorj, L Bereznicki, D Rowett, JN Ho, A Freeman, ... Exploratory Research in Clinical and Social Pharmacy 10, 100268, 2023 | 2 | 2023 |
| Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial G Dorj, NP Nair, L Bereznicki, TL Kelly, N Pratt, L Kalisch-Ellett, ... Drugs & Aging 40 (1), 49-58, 2023 | 2 | 2023 |
| Exploring what matters to residents of Australian aged care facilities with the Happy Life Index: comparison of qualitative responses between pre-and mid-Covid-19 pandemic time … CM Murray, S Milanese, M Guerin, R Bilton, KL Baldock, G Parfitt Quality of Life Research 32 (8), 2247-2257, 2023 | 1 | 2023 |
| Correction to: Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial G Dorj, NP Nair, L Bereznicki, TL Kelly, N Pratt, L Kalisch-Ellett, ... Drugs & Aging 40 (1), 89, 2023 | 1 | 2023 |
| The quality of care delivered to residents in long-term care in Australia: an indicator-based review of resident records (CareTrack Aged study) PD Hibbert, CJ Molloy, ID Cameron, LC Gray, RL Reed, LK Wiles, ... BMC medicine 22 (1), 22, 2024 | | 2024 |
| Correlation of frailty assessment metrics in one-year follow-up of aged care residents: a sub-study of a randomised controlled trial AQ Andrade, I Widagdo, R Lim, TL Kelly, G Parfitt, N Pratt, RL Bilton, ... Aging Clinical and Experimental Research 35 (10), 2081-2087, 2023 | | 2023 |
Jacques PouyssegurIRCAN, Centre A. Lacassagne, University of Nice and Centre Scientifique de Monaco (CSM)Verified email at unice.fr
